Oded Katash: "Jimmy Clark Will Play on Friday". What About Tamir Blatt?
Maccabi Tel Aviv coach Oded Katash summed up the game and addressed the injured players. Hord: "The final? It will be like hell"
Sport 5 Published: 10.06.26, 23:22
A win away from the final. Maccabi Tel Aviv defeated Hapoel Holon 74:84 on Wednesday night and took a 0:2 lead in the playoff semifinal series. The win came behind a huge career-best performance from Jaylen Hord, who finished with 30 points, 15 rebounds and a 35 efficiency rating.
The Yellow coach Oded Katash summed up: "I think defensively we did a much better job for many minutes. Two games in 48 hours, we did not come in with many guards and Tamir Blatt's injury disrupted our plans, we hope it's not a major blow. We grabbed a lot of offensive rebounds, Jaylen was tremendous."
On what led to the victory: "We made adjustments, we talked before the game about their transition game, the post defense was good and we were better defensively. On offense, once Tamir got injured, we had to do things we're not used to. We won by using our size, offensive rebounding, they also did not shoot well."
The coach added: "Blatt's situation? I am buying the scenario that it will be for one game only and no more. Let's hope Jimmy Clark returns and returns well, he will play in the third game of the series."
Hord summed up the standout performance: "I felt good helping the team. I just played with energy and aggressiveness, and that helped the team, my teammates found me, including the bigs. The goal is to finish the story in the next game. I think we can go all the way, if we reach the final it will be hellishly difficult. The fans always bring amazing energy in every competition and give us a lot of strength."
Premier League in basketball
Spotted a language error?
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.